CEO: THIS is biggest threat to pharm research...
Share

CEO: THIS is biggest threat to pharm research...

Robert Mulroy, Merrimack CEO, discusses the risk factors and time element it takes to create innovative drugs as R&D costs rise and pharma consolidation continues.
03:50
Thu, Nov 5 20156:42 AM EST